These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 23463541)

  • 1. Can C-peptide mediated anti-inflammatory effects retard the development of microvascular complications of type 1 diabetes?
    Luppi P; Kallas Å; Wahren J
    Diabetes Metab Res Rev; 2013 Jul; 29(5):357-62. PubMed ID: 23463541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of C-peptide on microvascular blood flow and blood hemorheology.
    Forst T; Kunt T
    Exp Diabesity Res; 2004; 5(1):51-64. PubMed ID: 15198371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-peptide, Na+,K(+)-ATPase, and diabetes.
    Vague P; Coste TC; Jannot MF; Raccah D; Tsimaratos M
    Exp Diabesity Res; 2004; 5(1):37-50. PubMed ID: 15198370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-peptide replacement therapy as an emerging strategy for preventing diabetic vasculopathy.
    Bhatt MP; Lim YC; Ha KS
    Cardiovasc Res; 2014 Nov; 104(2):234-44. PubMed ID: 25239825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Proinsulin C-peptide -- the bioactive peptide with a huge promise].
    Walenciak Ł; Fendler W; Młynarski W
    Pediatr Endocrinol Diabetes Metab; 2007; 13(2):95-8. PubMed ID: 17880815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type 1 diabetic neuropathy and C-peptide.
    Sima AA; Zhang W; Grunberger G
    Exp Diabesity Res; 2004; 5(1):65-77. PubMed ID: 15198372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of proinsulin C-peptide on nitric oxide, microvascular blood flow and erythrocyte Na+,K+-ATPase activity in diabetes mellitus type I.
    Forst T; De La Tour DD; Kunt T; Pfützner A; Goitom K; Pohlmann T; Schneider S; Johansson BL; Wahren J; Löbig M; Engelbach M; Beyer J; Vague P
    Clin Sci (Lond); 2000 Mar; 98(3):283-90. PubMed ID: 10677386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-peptide makes a comeback.
    Wahren J; Jörnvall H
    Diabetes Metab Res Rev; 2003; 19(5):345-7. PubMed ID: 12951641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of endothelial dysfunction with development of type 1 diabetes mellitus: role of insulin and C-peptide.
    Joshua IG; Zhang Q; Falcone JC; Bratcher AP; Rodriguez WE; Tyagi SC
    J Cell Biochem; 2005 Dec; 96(6):1149-56. PubMed ID: 16187296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proinsulin C-peptide abrogates type-1 diabetes-induced increase of renal endothelial nitric oxide synthase in rats.
    Kamikawa A; Ishii T; Shimada K; Makondo K; Inanami O; Sakane N; Yoshida T; Saito M; Kimura K
    Diabetes Metab Res Rev; 2008; 24(4):331-8. PubMed ID: 18088079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-inflammatory and anti-angiogenic effect of long chain n-3 polyunsaturated fatty acids in intestinal microvascular endothelium.
    Ibrahim A; Mbodji K; Hassan A; Aziz M; Boukhettala N; Coëffier M; Savoye G; Déchelotte P; Marion-Letellier R
    Clin Nutr; 2011 Oct; 30(5):678-87. PubMed ID: 21632157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmune-mediated oxidative stress and endothelial dysfunction: implications of accelerated vascular injury in type I diabetes.
    Zimmerman MA; Flores SC
    J Surg Res; 2009 Jul; 155(1):173-8. PubMed ID: 18805553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New aspects on biological activity of C-peptide in IDDM patients.
    Forst T; Kunt T; Pfützner A; Beyer J; Wahren J
    Exp Clin Endocrinol Diabetes; 1998; 106(4):270-6. PubMed ID: 9792458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pathophysiological and clinical implications of AT(1) and AT(2) angiotensin II receptors in metabolic disorders: hypercholesterolaemia and diabetes].
    Strawn WB
    Drugs; 2002; 62 Spec No 1():31-41. PubMed ID: 12036387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological Activity of c-Peptide in Microvascular Complications of Type 1 Diabetes-Time for Translational Studies or Back to the Basics?
    Ryk A; Łosiewicz A; Michalak A; Fendler W
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33419247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proinsulin C-peptide prevents type-1 diabetes-induced decrease of renal Na+-K+-ATPase alpha1-subunit in rats.
    Nordquist L; Shimada K; Ishii T; Furuya DT; Kamikawa A; Kimura K
    Diabetes Metab Res Rev; 2010 Mar; 26(3):193-9. PubMed ID: 20225182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes mellitus: The linkage between oxidative stress, inflammation, hypercoagulability and vascular complications.
    Domingueti CP; Dusse LM; Carvalho Md; de Sousa LP; Gomes KB; Fernandes AP
    J Diabetes Complications; 2016; 30(4):738-45. PubMed ID: 26781070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-peptide and long-term complications of diabetes.
    Luppi P; Cifarelli V; Wahren J
    Pediatr Diabetes; 2011 May; 12(3 Pt 2):276-92. PubMed ID: 21129141
    [No Abstract]   [Full Text] [Related]  

  • 19. Acute hyperglycemia and hyperinsulinemia enhance vasodilatation in Type 1 diabetes mellitus without increasing capillary permeability and inducing endothelial dysfunction.
    Oomen PH; Kant GD; Dullaart RP; Reitsma WD; Smit AJ
    Microvasc Res; 2002 Jan; 63(1):1-9. PubMed ID: 11749067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased plasma markers of inflammation and endothelial dysfunction and their association with microvascular complications in Type 1 diabetic patients without clinically manifest macroangiopathy.
    Targher G; Bertolini L; Zoppini G; Zenari L; Falezza G
    Diabet Med; 2005 Aug; 22(8):999-1004. PubMed ID: 16026364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.